Beijing Biostar Pharmaceuticals Co., Ltd. (HKG:2563)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
4.100
-0.050 (-1.20%)
Sep 18, 2026, 3:55 PM HKT

HKG:2563 Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1,4951,7837,182---
Market Cap Growth
-52.44%-75.18%----
Enterprise Value
9801,2116,639---
Last Close Price
4.104.8919.70---

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
23.4548.0293.92---
PB Ratio
2.022.408.54---
P/TBV Ratio
2.062.458.68---

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
15.3832.6186.82---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.000.000.000.000.000.00
Net Debt / Equity Ratio
-0.70-0.68-0.72-0.79-0.84-0.85
Net Debt / EBITDA Ratio
5.063.503.552.773.932.81
Net Debt / FCF Ratio
-2.903.733.226.548.95
Asset Turnover
0.070.040.090.080.040.07
Inventory Turnover
0.090.070.330.680.330.29
Quick Ratio
7.477.537.5413.5314.8545.76
Current Ratio
8.778.338.8314.4815.5647.70
Return on Equity (ROE)
-15.00%-18.04%-18.99%-23.84%-17.72%-28.90%
Return on Assets (ROA)
-7.69%-10.34%-12.59%-15.93%-12.84%-18.74%
Return on Capital Employed (ROCE)
-14.50%-19.80%-20.40%-29.70%-22.20%-31.10%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-8.03%-8.20%-2.13%---
FCF Yield
--9.80%-2.27%---
Buyback Yield / Dilution
-1.48%-4.11%-0.19%---